Published in TB and Outbreaks Week, April 10th, 2007
This agreement will permit StormBio to develop a new class of therapeutics to save lives and reduce disability from flu and other inflammatory diseases.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.